(2022) New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report. CLINICAL CASE REPORTS. ISSN 2050-0904 J9 - CLIN CASE REP
Full text not available from this repository.
Abstract
Development of pemphigus foliaceus (PF) following SARS-CoV-2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug-induced case of PF. Here, we reported the first case of PP arising solely after COVID infection without taking any culprit drug.
| Item Type: | Article |
|---|---|
| Keywords: | COVID-19 multiple sclerosis pemphigus pemphigus foliaceus rituximab SARS-Cov-2 VULGARIS |
| Journal or Publication Title: | CLINICAL CASE REPORTS |
| Journal Index: | ISI |
| Volume: | 10 |
| Number: | 6 |
| Identification Number: | https://doi.org/10.1002/ccr3.5910 |
| ISSN: | 2050-0904 J9 - CLIN CASE REP |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/16182 |
Actions (login required)
 |
View Item |